All In MedTech

FDA Clearance Tracker · P150035-S030

Aveir VR Delivery Catheter LSCD111; Aveir DR Delivery Catheter LSCD201

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 17, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 17, 2025

Approved

Time to decision

56 days

Received Jul 23, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P150035-S030
Device name
Aveir VR Delivery Catheter LSCD111; Aveir DR Delivery Catheter LSCD201
Applicant location
Sylmar, CA
Received
Jul 23, 2025
Decided
Sep 17, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P150035

Device type

Device class
Class III
Regulation
21 CFR 870.3610

Every decision under product code PNJ

FDA's approval statement

As written in FDA's record.

to add Midwest Sterilization Corporation as an alternate Ethylene Oxide (EO) sterilization site for the Aveir VR and Aveir DR Delivery Catheters

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.